Medication Usage

Eflornithine (Cream) is a prescription medication applied to the skin for the reduction of unwanted facial hair in women. Eflornithine interferes with an enzyme found in the hair follicle of the skin needed for hair growth. This results in slower hair growth and improved appearance where Eflornithine is applied. Eflornithine does not permanently remove hair or "cure" unwanted facial hair. It is not a depilatory. Your treatment program should include continuation of any hair removal technique you are currently using. Eflornithine will help you manage your condition and improve your appearance.

Medication Consumption

Apply a thin layer of Eflornithine Cream to affected areas of the face and adjacent involved areas under the chin and rub in thoroughly. Do not wash treated area for at least 4 hours. Use twice daily at least 8 hours apart or as directed by a physician. You should continue to use hair removal techniques as needed in conjunction with Eflornithine. (Eflornithine should be applied at least 5 minutes after hair removal). Cosmetics or sunscreens may be applied over treated areas after cream has dried.

Warnings/Cautions

Do not use Eflornithine if you have had an allergic reaction to it in the past. Eflornithine is in the FDA pregnancy category C. This means that it is not known whether Eflornithine will harm an unborn baby. Do not use this medication without first talking to your doctor if you are pregnant. It is also not known whether Eflornithine passes into breast milk. Do not use Eflornithine without first talking to your doctor if you are breast-feeding a baby. Eflornithine has not been approved for use by children younger than 12 years of age.

Missed Dose

If you forget or miss a dose of Eflornithine do not try to "make it up". Return to your normal application schedule as soon as you can.

Serious Side Effects

Eflornithine may cause temporary redness, stinging, burning, tingling or rash on areas of the skin where it is applied. Hair bumps may also occur. If these persist, consult your doctor. Treatment related skin adverse events that occurred in less than 1% of the subjects treated with Eflornithine are: bleeding skin, cheilitis, and contact dermatitis, swelling of lips, herpes simplex, numbness and rosacea. Adverse events were primarily mild in intensity and generally resolved without medical treatment or discontinuation of Eflornithine.

How Kept

Store at 25° C (77° F); excursions permitted to 15° C-30° C (59° F-86° F). Do not freeze. See tube crimp and carton end for expiration date and lot number.

Possible Overdose

An overdose of Eflornithine is not likely to occur. If the cream has been ingested, or if you suspect an overdose has occurred, contact your doctor, hospital emergency room, or poison control center for advice.

Special Information

Avoid getting this medication in your eyes, nose, or mouth. If this occurs, wash the area with water. If Eflornithine gets in your eyes, rinse thoroughly with water and contact your doctor.

Information Disclaimer

This drug information is for your information purposes only. No warranty, either expressed or implied, is made in regards to this information.